Contents
1. The short answer
21 CFR Part 11 is a US FDA regulation on electronic records and electronic signatures. EU GMP Annex 11 is European guidance on computerised systems used in GxP. They cover much of the same ground — audit trails, access control, data integrity, validation — but Part 11 is narrower and prescriptive about records and signatures, while Annex 11 is broader across the whole system lifecycle. If you sell into both markets you must map to both; satisfying one does not automatically satisfy the other.
2. What each one governs
21 CFR Part 11 sets the conditions under which the FDA will accept electronic records and electronic signatures as equivalent to paper and handwritten ones. Its core demands: validated systems, secure and time-stamped audit trails, authority checks, and signature controls (unique, attributable, non-repudiable).
EU GMP Annex 11 governs computerised systems in the wider GMP context. It reaches beyond records into risk management, supplier and service-provider management, the system lifecycle (from URS through decommissioning), data storage, business continuity and periodic review.
3. Side by side
| Dimension | 21 CFR Part 11 (US FDA) | EU GMP Annex 11 (EU) |
|---|---|---|
| Type | Regulation (enforceable law) | GMP guidance (annex to the GMP guide) |
| Primary focus | Electronic records & signatures | Computerised systems, whole lifecycle |
| Signatures | Detailed, prescriptive requirements | Addressed, less prescriptive |
| Risk management | Implied via validation | Explicit, risk-based throughout |
| Supplier management | Not detailed | Explicit (audits, agreements) |
| Audit trail | Required, secure, time-stamped | Required, reviewed risk-based |
| Lifecycle scope | Focused on records in use | URS → operation → decommission |
4. Where they overlap — and diverge
The overlap is large: both demand validated systems, secure audit trails, access control tied to authority, and demonstrable data integrity (ALCOA+ principles). A system built well for one is most of the way to the other.
The divergence is in emphasis and coverage. Part 11 goes deeper on signature mechanics — what makes an electronic signature legally equivalent, how it binds to the record, how it resists repudiation. Annex 11 goes wider on governance — how you manage the supplier, assess risk, run the lifecycle and review the system periodically. A clause-by-clause cross-map is the honest way to know your gaps; assuming equivalence leaves holes an inspector finds.
5. What this means for your system
For any computerised system in a GxP decision path, the practical programme is: validate risk-based (GAMP 5), implement secure time-stamped audit trails and authority-bound access, control electronic signatures to Part 11 specifics, and wrap it in Annex 11 lifecycle governance (supplier management, periodic review, business continuity). Then maintain a single traceability matrix that maps each control to both frameworks.
This is the standard Synlogica Terminus is built to answer: every decision package is version-pinned and reproducible bit-for-bit, with a secure audit trail and e-signature controls, and the Quality module (Terminus M4) is documented as GAMP 5 Category 4 configurable software — so it slots into both a Part 11 and an Annex 11 mapping. The validation and compliance evidence is indexed in our trust pack, and the classification rationale is in the GAMP 5 Category 4 white paper.
6. FAQ
Do I need to comply with both 21 CFR Part 11 and EU GMP Annex 11?
If you place product in both the US and EU markets, effectively yes. They overlap heavily but are not identical — Part 11 focuses on electronic records and signatures; Annex 11 covers the broader computerised-system lifecycle. Map your system to both.
What is the biggest practical difference between them?
Emphasis. Part 11 is prescriptive about electronic signatures and record controls; Annex 11 is broader on lifecycle, supplier management, risk and data integrity. A control that satisfies one may need extra evidence to satisfy the other.
Does meeting Annex 11 mean I automatically meet Part 11?
No. There is substantial overlap, but each has requirements the other does not spell out the same way. Cross-map clause by clause rather than assuming equivalence.
7. References
- 21 CFR Part 11 — Electronic Records; Electronic Signatures (US FDA).
- EudraLex Volume 4, EU GMP Annex 11 — Computerised Systems.
- FDA Guidance for Industry — Part 11, Scope and Application.
- ISPE GAMP 5, Second Edition (2022); ISPE GAMP Records & Data Integrity Good Practice Guide.